Sabestomig is a monoclonal antibody commercialized by AstraZeneca, with a leadin...
AZD-9574 is a small molecule commercialized by AstraZeneca, with a leading Phase...
MK-1084 is a small molecule commercialized by Merck, with a leading Phase I prog...
XXB-750 is a monoclonal antibody commercialized by Novartis, with a leading Phas...
NNC0519-0130 is commercialized by Novo Nordisk, with a leading Phase II program...
LY-3972406 is a small molecule commercialized by Eli Lilly and Co, with a leadin...
PF-07275315 is a monoclonal antibody commercialized by Pfizer, with a leading Ph...
ELVN-002 is a small molecule commercialized by Enliven Therapeutics, with a lead...
NN-9931 is a recombinant peptide commercialized by Novo Nordisk, with a leading ...
Moderna has announced the halt of its project to build a messenger ribonucleic a...
The site expansion is set to add 680 jobs to the site and expand Fujifilm’s cont...
Eliem Therapeutics has announced an agreement for the acquisition of development...
Novartis has signed an exclusive strategic licence agreement for Arvinas’ ARV-76...
The US FDA has granted approval for AstraZeneca's FASENRA in children aged six t...
The collaboration pact will see Rallybio gaining a $6.6m equity investment from ...
As the UK tackles several drug shortages, UK charities and pharmacists called fo...
